Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Brehler

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Allergy|December 17, 2008
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT studyH Ott, J Sieber, R Brehler, et al.
Allergy|September 22, 2009
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT studyH Ott, J Sieber, R Brehler, et al.
European Journal of Biochemistry|August 6, 1998
cDNA cloning of the 43-kDa latex allergen Hev b 7 with sequence similarity to patatins and its expression in the yeast Pichia pastorisS Sowka, S Wagner, M Krebitz, et al.
European Journal of Biochemistry|December 6, 2000
Hev b 9, an enolase and a new cross-reactive allergen from hevea latex and molds. Purification, characterization, cloning and expressionS Wagner, H Breiteneder, B Simon-Nobbe, et al.
International Archives of Allergy and Immunology|August 8, 2001
Hev b 8, the Hevea brasiliensis latex profilin, is a cross-reactive allergen of latex, plant foods and pollenE Ganglberger, C Radauer, S Wagner, et al.
Allergy|January 18, 2006
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response studyT Werfel, K Breuer, F Ruéff, et al.
Human Vaccines & Immunotherapeutics|June 15, 2022
Update about Oralair® as a treatment for grass pollen allergic rhinitisL Klimek, R Brehler, R Mösges, et al.
The Journal of Allergy and Clinical Immunology|December 10, 1999
Molecular and immunologic characterization of new isoforms of the Hevea brasiliensis latex allergen hev b 7: evidence of no cross-reactivity between hev b 7 isoforms and potato patatin and proteins from avocado and bananaS Sowka, C Hafner, C Radauer, et al.
The British Journal of Dermatology|April 17, 2010
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosusA Kuhn, A M Meuth, D Bein, et al.
Allergy|December 21, 2016
BASALIT trial: double-blind placebo-controlled allergen immunotherapy with rBet v 1-FV in birch-related soya allergyR Treudler, A Franke, A Schmiedeknecht, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Allergy|December 17, 2008
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT studyH Ott, J Sieber, R Brehler, et al.
Allergy|September 22, 2009
Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT studyH Ott, J Sieber, R Brehler, et al.
European Journal of Biochemistry|August 6, 1998
cDNA cloning of the 43-kDa latex allergen Hev b 7 with sequence similarity to patatins and its expression in the yeast Pichia pastorisS Sowka, S Wagner, M Krebitz, et al.
European Journal of Biochemistry|December 6, 2000
Hev b 9, an enolase and a new cross-reactive allergen from hevea latex and molds. Purification, characterization, cloning and expressionS Wagner, H Breiteneder, B Simon-Nobbe, et al.
International Archives of Allergy and Immunology|August 8, 2001
Hev b 8, the Hevea brasiliensis latex profilin, is a cross-reactive allergen of latex, plant foods and pollenE Ganglberger, C Radauer, S Wagner, et al.
Allergy|January 18, 2006
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response studyT Werfel, K Breuer, F Ruéff, et al.
Human Vaccines & Immunotherapeutics|June 15, 2022
Update about Oralair® as a treatment for grass pollen allergic rhinitisL Klimek, R Brehler, R Mösges, et al.
The Journal of Allergy and Clinical Immunology|December 10, 1999
Molecular and immunologic characterization of new isoforms of the Hevea brasiliensis latex allergen hev b 7: evidence of no cross-reactivity between hev b 7 isoforms and potato patatin and proteins from avocado and bananaS Sowka, C Hafner, C Radauer, et al.
The British Journal of Dermatology|April 17, 2010
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosusA Kuhn, A M Meuth, D Bein, et al.
Allergy|December 21, 2016
BASALIT trial: double-blind placebo-controlled allergen immunotherapy with rBet v 1-FV in birch-related soya allergyR Treudler, A Franke, A Schmiedeknecht, et al.
Pageof 7